Roger Jeffs Sells 25,000 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 25,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $61.13, for a total transaction of $1,528,250.00. Following the transaction, the chief executive officer directly owned 1,098,095 shares in the company, valued at approximately $67,126,547.35. This represents a 2.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Tuesday, May 26th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $60.38, for a total transaction of $1,509,500.00.
• On Tuesday, May 19th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $58.65, for a total transaction of $1,466,250.00.
• On Friday, May 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $57.04, for a total transaction of $1,426,000.00.
• On Wednesday, May 13th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $56.29, for a total transaction of $1,407,250.00.
• On Monday, May 11th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $41.50, for a total transaction of $1,037,500.00.
• On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $42.09, for a total transaction of $1,052,250.00.
• On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.10, for a total transaction of $1,002,500.00.
• On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The stock was sold at an average price of $40.60, for a total transaction of $764,863.40.
• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total transaction of $1,003,500.00.
• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The stock was sold at an average price of $40.00, for a total transaction of $132,000.00.

Liquidia Price Performance

Liquidia stock opened at $62.03 on Thursday. Liquidia Corporation has a 52-week low of $11.85 and a 52-week high of $63.46. The firm has a fifty day moving average of $43.52 and a 200-day moving average of $38.05. The firm has a market capitalization of $5.52 billion, a P/E ratio of 443.10 and a beta of 0.41. The company has a quick ratio of 2.03, a current ratio of 2.22 and a debt-to-equity ratio of 1.18.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The company had revenue of $132.87 million during the quarter, compared to analyst estimates of $119.44 million. The business’s revenue was up 4187.1% compared to the same quarter last year. As a group, analysts predict that Liquidia Corporation will post 2.97 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on LQDA shares. Jefferies Financial Group reissued a “buy” rating and issued a $60.00 price objective on shares of Liquidia in a research report on Monday, May 11th. Oppenheimer increased their price objective on shares of Liquidia from $16.00 to $19.00 and gave the stock an “underperform” rating in a research report on Thursday, March 12th. Zacks Research raised shares of Liquidia from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a research report on Tuesday, April 21st. Finally, HC Wainwright increased their price objective on shares of Liquidia from $55.00 to $67.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Three investment analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $50.88.

Institutional Investors Weigh In On Liquidia

A number of large investors have recently added to or reduced their stakes in the company. Segall Bryant & Hamill LLC acquired a new stake in Liquidia during the 1st quarter valued at $2,111,000. Bank of America Corp DE grew its holdings in Liquidia by 18.7% during the 1st quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock valued at $86,341,000 after purchasing an additional 360,372 shares in the last quarter. California State Teachers Retirement System grew its holdings in Liquidia by 25.0% during the 1st quarter. California State Teachers Retirement System now owns 72,438 shares of the company’s stock valued at $2,734,000 after purchasing an additional 14,485 shares in the last quarter. Empowered Funds LLC acquired a new stake in Liquidia during the 1st quarter valued at $3,650,000. Finally, Eversept Partners LP grew its holdings in Liquidia by 33.0% during the 1st quarter. Eversept Partners LP now owns 677,392 shares of the company’s stock valued at $25,565,000 after purchasing an additional 167,949 shares in the last quarter. 64.54% of the stock is owned by institutional investors and hedge funds.

Liquidia News Roundup

Here are the key news stories impacting Liquidia this week:

• Positive Sentiment: Liquidia announced that CEO Roger Jeffs and CFO/COO Michael Kaseta will present a business update at the 2026 Jefferies Global Healthcare Conference on June 3, which can help keep investor attention on the company and its growth story. Article Title
• Positive Sentiment: Analysts continue to view Liquidia favorably, with the stock carrying a “Moderate Buy” consensus and several firms recently lifting price targets or upgrading ratings, which supports the rally. Article Title
• Neutral Sentiment: Insider filings showed CEO Roger Jeffs and Director Raman Singh sold shares in recent days, including a 25,000-share sale by the CEO under a pre-arranged 10b5-1 plan; while these trades can raise caution, the sales were disclosed and do not necessarily signal a change in operating outlook. Article Title

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).